Otsuka loses lawsuit challenging FDA approval of generic Abilify
May 28, 2015 at 12:42 PM EDT
May 28 (Reuters) - Otsuka Pharmaceutical Co Ltd has lost a lawsuit challenging the U.S. Food and Drug Administration's decision to allow generic versions of the company's antipsychotic drug Abilify.
